STOCK TITAN

Centessa Pharmaceuticals plc American (CNTA) Revenue by Year

CNTA NASDAQ

Centessa Pharmaceuticals plc American generated $15.0M in revenue in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Centessa Pharmaceuticals plc American has filed alongside them.

FY2025 annual
Revenue $15.0M
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNTA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$15.0Mn/m$0-100.0%$6.9Mn/m$0N/AN/AN/A

CNTA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Revenue$0-100.0%N/A$0n/m$0n/m$15.0Mn/mN/A$0$0$0N/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Centessa Pharmaceuticals plc American financials

Frequently Asked Questions

What was Centessa Pharmaceuticals plc American's revenue in fiscal year 2025?

Centessa Pharmaceuticals plc American generated $15.0M in revenue in fiscal year 2025.

How fast is Centessa Pharmaceuticals plc American's revenue growing?

Centessa Pharmaceuticals plc American (CNTA) reported $0 in revenue in fiscal year 2024 and $15.0M in revenue in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What was Centessa Pharmaceuticals plc American's revenue in the most recent quarter?

Centessa Pharmaceuticals plc American (CNTA) reported $0 in revenue in Q1 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Centessa Pharmaceuticals plc American (CNTA) reported on that line in every period on record.